The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte GABRIEL LOPEZ-BERESTEIN,
ANA M. TARI and SOO-JEONG LIM
__________
Appeal No. 2006-0762
Application No. 09/982,113
__________
ON BRIEF
__________
Before SCHEINER, GRIMES, and GREEN, Administrative Patent Judges.
GREEN, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s
final rejection of claims 138-141, which read as follows:
138. A method of treating a subject having cancer, comprising
administering to said individual a therapeutically effective amount of a
composition comprising N-(4-hydroxyphenyl) retamide, or a derivative thereof,
encapsulated in a lipid material, wherein the lipid material comprises dimyristoyl
phosphatidylcholine (DMPC) and water.
139. The method of claim 138, wherein the composition comprises from
1 to 10% water.
Page: 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007